載入...

Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

BACKGROUND: This study forms part of the first complete characterization of the dose–response curve for glycopyrrolate (GP) delivered using Co-Suspension™ Delivery Technology via a metered dose inhaler (MDI). We examined the lower GP MDI dose range to determine an optimal dose for patients with mode...

全面介紹

Na minha lista:
書目詳細資料
發表在:Respir Res
Main Authors: Fabbri, Leonardo M., Kerwin, Edward M., Spangenthal, Selwyn, Ferguson, Gary T., Rodriguez-Roisin, Roberto, Pearle, James, Sethi, Sanjay, Orevillo, Chad, Darken, Patrick, St. Rose, Earl, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5009486/
https://ncbi.nlm.nih.gov/pubmed/27586537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0426-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!